Johnson & Johnson Is Said to Win a Bid for the Cancer Drug Maker Pharmacyclics
Thursday, March 5, 2015 - 00:00
in Mathematics & Economics
If completed, a deal for Pharmacyclics, which makes a biopharmaceutical treatment for a type of lymphoma, would be among the big recent acquisitions in health care.